Anatomic Stage I Breast Cancer AJCC v8 Clinical Trials
118 clinical trials for Anatomic Stage I Breast Cancer AJCC v8 across international registries, including 33 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors — RECRUITING · NA
- Neoadjuvant Breast Cancer Time Restricted Eating — RECRUITING · PHASE2
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer — RECRUITING · NA
- 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss — RECRUITING · PHASE2
- Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer — RECRUITING · NA
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab — RECRUITING · PHASE3
- Breast Cancer, Reasoning, and Activity Intervention — RECRUITING · NA
- Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer — RECRUITING · PHASE1
- Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors — RECRUITING · PHASE2
- Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients — RECRUITING · PHASE2
- Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer — RECRUITING · NA
- Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial — RECRUITING · PHASE2
- Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial — RECRUITING · PHASE2
- Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial — RECRUITING · NA
- Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer — RECRUITING
- Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial — RECRUITING · NA
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy — RECRUITING · PHASE3
- Breast Cancer Survivorship Biorepository — RECRUITING
- Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer — RECRUITING · PHASE2
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy — RECRUITING
- Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial — RECRUITING · PHASE3
- A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial — RECRUITING · PHASE2
- Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial — RECRUITING · PHASE2
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — RECRUITING · NA
- Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer — RECRUITING
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer — RECRUITING · PHASE1
- Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer — RECRUITING · NA
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer — RECRUITING · PHASE1
- The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients — RECRUITING
- Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer — RECRUITING · PHASE2
- Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction — RECRUITING · PHASE2
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer — RECRUITING · PHASE3
- Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer — RECRUITING · PHASE2
- Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · NA
- Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Integrative Approaches for Cancer Survivorship (IACS3) — ACTIVE_NOT_RECRUITING · NA
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors — ACTIVE_NOT_RECRUITING
- Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial — NOT_YET_RECRUITING · NA
- A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden — NOT_YET_RECRUITING · PHASE2
- High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer — SUSPENDED · PHASE2
- Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations — TERMINATED · PHASE2
- Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer — WITHDRAWN · NA
- A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial — NOT_YET_RECRUITING · NA
- T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial — ACTIVE_NOT_RECRUITING · PHASE3
- A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors — COMPLETED · NA
- Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer — ACTIVE_NOT_RECRUITING
- Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer — TERMINATED · PHASE4
- Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients — NOT_YET_RECRUITING · PHASE2
- Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer — TERMINATED · NA
- Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery — COMPLETED · PHASE2
Refine this search